You may access the course via the following links:

19A Electronic

19A Booklet

The 19B links will be available in October 2022.

You can only access courses that you purchased or are complimentary. To access all of your courses, log into asahq.org/MyCourses. Or,  via the ASAHQ.org homepage, hover over the Education & CME tab on the main menu, and click on “My Courses.”

After successfully completing this activity, the learner will be able to

• Assess the current state of his or her knowledge of fundamental and subspecialty anesthesia topics and identify knowledge gaps
• Develop a strategy to address identified gaps using resources provided as references within the program
• Utilize enhanced knowledge in clinical practice
• Describe system changes that will result in the avoidance of, or recovery from, preventable harm to patients

Joel O. Johnson, MD, PhD
Co-Editor-in-Chief
Madison, Wisconsin

Stacy L. Jones, MD, MHA, FASA
Co-Editor-in-Chief
Little Rock, Arkansas

Shamsuddin Akhtar, MD 
New Haven, Connecticut

Kallol Chaudhuri, MD, PhD
Lubbock, Texas

Richard P. Dutton, MD, MBA, FASA
Dallas, Texas

Bhargavi Gali, MD
Rochester, Minnesota

Jennifer M. Hah, MD
Stanford, California

Russell K. McAllister, MD, FASA
Temple, Texas

Sara Robertson, MD, FASA
Madison, Mississippi

Kathryn Rouine-Rapp, MD
San Francisco, California

Johannes W. Steyn, MD
Nicholasville, Kentucky

Kofi B. Vandyck, MD
Oklahoma City, Oklahoma 

Additional Contributor: Christopher J. Lace, MD, MBA, Denver, Colorado
ASA Staff: Ginger Clark, Managing Editor

Resolution of Conflicts of Interest: ASA remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of ASA to eliminate all situations of potential conflict of interest, but rather to enable those who are working with ASA to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. ASA educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ASA activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The faculty and staff below have reported the following financial relationships with ineligible companies:

Ginger Clark
Merck: Stock (self)
Organon & Co: Stock (self)

Jennifer M. Hah, MD
Nalu Medical: Independent contractor—consultant (self)
SPR Therapeutics, Inc: Independent contractor—consultant (self)

Kofi B. Vandyck, MD
Abiomed: Stock (self)
Medtronic: Stock (self)
General Electric: Stock (self)
Johnson & Johnson Health Care Systems Inc: Stock (self)
Edwards Lifesciences: Stock (self)
Quantra QStat Study: Independent contractor—other (self)

All disclosed financial relationships have been mitigated. All other faculty, planners, and staff have reported no financial relationships with ineligible companies.